Form 4: Bluebird Bio's Chief Medical Officer Sells Shares to Cover Tax Obligations

Richard A. Colvin, Chief Medical Officer of bluebird bio, Inc., sold 19 shares of common stock on January 6, 2025, to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• Richard A. Colvin, the Chief Medical Officer of bluebird bio, Inc., reported a transaction involving the company's common stock.
• On January 6, 2025, Colvin sold 19 shares at a price of $9.24 per share.
• The sale was executed to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
• Following the transaction, Colvin beneficially owns 8,257 shares of bluebird bio, Inc.
• The reporting person has a power of attorney designating individuals to act on their behalf for Section 13 and Section 16 filings.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to stock transactions by an insider. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to the market.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on stakeholders as it is a small sale of shares by an executive to cover tax obligations.

Key Dates